There are 25 papers on gastric adenocarcinoma in aging research: 2 trials and 16 observational studies in people, 2 in cells, 1 review.
25 papers study it10 more mention it4 findings
2 new papers in 30 daysSee all 35 papers on gastric adenocarcinoma
“Increasing calcium intake was associated with lower risk of GA overall (p-trend = 0.05)”
- Human trial2
- Humans16
- Cells2
- In silico4
Associations
4ADH1B*2 plus ALDH2*2
upin humans1OR 3.71
1 study
ADH1B*2 plus ALDH2*2
upin humans1OR 3.71
ADH1B*2 plus ALDH2*2 is associated with gastric adenocarcinoma in humans (Japanese alcohol-dependent men; versus ADH1B*2 plus ALDH2*1/*1) (OR 3.71 (95% CI 2.19–6.30)).
HumansJapanese alcohol-dependent men; versus ADH1B*2 plus ALDH2*1/*1stomachmalesn = 10,073
Hormone replacement therapy
downin humans1OR 0.9
1 study
Hormone replacement therapy
downin humans1OR 0.9
Hormone replacement therapy is linked with a lower risk of gastric adenocarcinoma in humans (compared with nonuse) (OR 0.90, 95% CI 0.84-0.96).
Humanscompared with nonuse<158 to >848 DDDsfemales
Esophagogastroduodenoscopy
upin humans1
1 study
Esophagogastroduodenoscopy
upin humans1
Esophagogastroduodenoscopy is associated with gastric adenocarcinoma in humans during colonoscopy within colorectal cancer screening (0.8% (3/377)).
Humansduring colonoscopy within colorectal cancer screeningstomachone-timen = 377
Calcium
downin humans1
1 study
Calcium
downin humans1
Calcium is linked with a lower risk of gastric adenocarcinoma in humans (p-trend = 0.05).
Humansdietary and supplemental intake
Trial sponsors
Company4 trialsPhase 3732 people
Company3 trialsPhase 31,673 people
Company3 trialsPhase 3617 people
Company2 trialsPhase 3968 people
Company2 trialsPhase 3948 people
Company1 trialPhase 3780 people
NingBo Junyan Hongshi Biosciences
Company1 trialPhase 3600 people
Company1 trialPhase 3479 people
Funding
1 grant since 2022National Cancer Institute$4.6M